Meet ApplyKite Twin, the application assistant that learns with you
Meet your Twin, it learns with you
Your Twin learns with you
Launch week codes:30% off annual Pro20% off monthly Pro
Ends in00h00m00s
Ends in00h00m00s
Allison Bernknopf
Professor
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (8)
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Drug information specialists (DIS) bring unique, specialized expertise and provide services in diverse settings including health systems, academia, pharmaceutical industry, compendia, medical writing, and other areas. With widespread access to drug information (DI) resources through user‐friendly, online platforms, the role of DIS has shifted. Core skill sets once confined to DIS are now distributed across various non‐DIS clinical specialties. DIS have transformed the application of their specialized skill set and adapted it to a variety of traditional and nontraditional areas, providing and applying advanced expertise to solve a variety of contemporary challenges. The training of students and residents has evolved to include evidence‐based practical contemporary methods that promote critical thinking and reasoning. Effective DI evaluation and communication necessitates customizing content for stakeholders to ensure understanding and contribute to optimal patient care, all while addressing misinformation and disinformation. The future of DI as a specialty is bright, with ever‐increasing recognition of the importance of DI skills in non‐DIS practitioners. DIS will likely continue to guide best practices in the education/training of new practitioners and continue to provide advanced services and formulary analytics. This update to our 2009 DI PRN Opinion paper will focus on: (1) DI education and training needed for all students, residents, and pharmacists; (2) career opportunities, roles, and responsibilities specifically tailored for DIS in health systems, managed care organizations, academia, pharmaceutical/biotechnology industry, and medical writing services; and (3) the future direction of DI, including the potential impact of artificial intelligence.
Year:
2024
Year:
2024
Year:
2024
Year:
2023
Collaborators (11)
May H. Abdel Aziz
-
Kristina E. Ward
University of Rhode Island
Micheline Goldwire
Professor/Director of Drug Information Services
Regis University
Taylor Thompson
Clinical Assistant Professor
West Virginia University
Casey Rowe
Clinical Assistant Professor
University of Florida
Karen Kier
Professor of Pharmacy Practice, Director of Drug and Health Information
Ohio Northern University
Ellen Jones
Assistant Professor of Pharmacy Practice
Harding University
Daniel Abazia
Clinical Associate Professor
Rutgers University
Kyle Gustafson
Associate Professor
Northeast Ohio Medical University
Jere May
Clinical Professor
University of Georgia
Elizabeth Yett
Assistant Professor
University of Tennessee Health Science Center
Make your next move.
Prepare your application
Review drafts before you send them.